Results 151 to 160 of about 12,351 (293)
Atypical Presentation of Cat-Scratch Disease in a 30-Year-Old Female: A Case Study. [PDF]
Khatrawi EM+4 more
europepmc +1 more source
Microcapsule‐based intelligent coatings (MICs) have shown great potential in the fields of biomedicine, smart buildings, marine protection, and aerospace. However, they currently face challenges in the integration of coating functions and applications in complex systems.
Yue Zhao+5 more
wiley +1 more source
Clinical Characteristics and Visual Outcomes of Cat Scratch Disease. [PDF]
Shi J, Cheema MR.
europepmc +1 more source
Cat Scratch Disease: 9 Years of Experience at a Pediatric Center. [PDF]
Amin O+15 more
europepmc +1 more source
Astrocytic ET‐1 System Determines Microglia Phenotype Following Spinal Cord Injury
The study reveals that astrocytic ET‐1 system is solely activated by thrombin following SCI via RhoA/NF‐κB and MAPKs/NF‐κB signal pathway. The release of astrocytic ET‐1 drives microglia polarization toward M1 phenotype through YAP signaling via ETA and ETB receptors.
Bingqiang He+11 more
wiley +1 more source
Kawasaki Disease or Cat Scratch Disease? A Diagnostic Dilemma: A Paediatric Case Report and Literature Review. [PDF]
Gorczyca D, Lewandowski D, Postępski J.
europepmc +1 more source
A Case of Cat Scratch Disease with Neuroretinitis in a 16-Month-Old Boy. [PDF]
Nakata D+6 more
europepmc +1 more source
ALKBH5 promoted G3BP1 expression via m⁶A methylation at sites 142/173. G3BP1 interacts with YBX1 and p53, reducing their nuclear translocation and decreasing p53‐mediated SLC7A11 repression. This inhibites cardiomyocyte ferroptosis and mitigates myocardial damage during diabetic ischemia‐reperfusion injury.
Wenyuan Li+5 more
wiley +1 more source
Magnetically Controllable and Degradable Milliscale Swimmers as Intraocular Drug Implants
Magnetically controllable degradable milliscale swimmers (MDMS) offer a promising alternative to commercial intraocular drug implants, reducing complications like implant dislocation and uncontrolled drug release. MDMS achieve high velocities in ocular environments, enable real‐time imaging, and deliver drugs effectively without disrupting retinal ...
Erdost Yildiz+8 more
wiley +1 more source